Skip to main content
. 2011 Aug 24;29(2):427–440. doi: 10.1007/s11095-011-0558-7

Fig. 10.

Fig. 10

Human pharmacokinetic data for the commercial capsule, resuspended nanoparticles (OPC), and resuspended HPMCAS SDD OPC.